Katherine Stueland
Chief Executive Officer at GENEDX HOLDINGS CORP.
Net worth: 847 457 $ as of 2024-04-29
Profile
Katherine A.
Stueland is currently the President, Chief Executive Officer & Director at GeneDx Holdings Corp.
She is also the President & Chief Executive Officer at GeneDx LLC.
Additionally, she holds positions as a Director at Cancan Health and as the President & Director at Sema4 OpCo, Inc. Previously, Ms. Stueland served as the President & Chief Executive Officer at GeneDx, Inc. She was also a Director at the Rivkin Center for Ovarian Cancer.
From 2011 to 2012, she worked as the VP-Corporate Communications & Investor Relations at Dendreon Corp.
From 2016 to 2021, she held the role of Chief Commercial Officer at Invitae Corp.
In 2013, she briefly worked as a Principal at Vivo Communications, LLC.
Ms. Stueland completed her undergraduate degree at Miami University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-28 | 75,869 ( 0.29% ) | 847 457 $ | 2024-04-29 |
Katherine Stueland active positions
| Companies | Position | Start |
|---|---|---|
| GENEDX HOLDINGS CORP. | Chief Executive Officer | 2022-04-28 |
| Cancan Health | Director/Board Member | - |
GeneDx LLC
 GeneDx LLC Medical/Nursing ServicesHealth Services Part of GeneDx Holdings Corp., GeneDx LLC is a private company that provides genomic testing services. The company is based in Stamford, CT. The company was founded in 2000. Katherine A. Stueland has been the CEO of the company since 2021. | Chief Executive Officer | 2021-05-31 |
Mount Sinai Genomics, Inc.
 Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | President | - |
Former positions of Katherine Stueland
| Companies | Position | End |
|---|---|---|
| INVITAE CORPORATION | Investor Relations Contact | 2016-09-30 |
Vivo Communications, LLC
 Vivo Communications, LLC Specialty TelecommunicationsCommunications Vivo Communications, LLC provides telecommunication services. The private company is based in Seattle, WA. | Corporate Officer/Principal | 2013-11-30 |
| DENDREON CORPORATION | Investor Relations Contact | 2012-05-31 |
GeneDx, Inc.
 GeneDx, Inc. Medical/Nursing ServicesHealth Services GeneDx, Inc. provides genetic testing for rare hereditary disorders. It offers diagnostic tests for gene, disease, mitochondria, inherited metabolic, and eye disorders; gene deletion/duplication analysis services; and molecular cytogenetic, prenatal genetic, mutation-specific, autism/autism spectrum disorder, cardiology genetic, and mutation confirmation tests. The company was founded by John Compton and Sherri Bale in 2000 and is headquartered in Gaithersburg, MD. | Chief Executive Officer | - |
Rivkin Center for Ovarian Cancer
 Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Rivkin Center for Ovarian Cancer is a non-profit organization that funds ovarian cancer research, screening, and educational programs for women. The company was founded by Saul E. Rivkin in 1996 and is headquartered in Seattle, WA. | Director/Board Member | - |
Training of Katherine Stueland
| Miami University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| INVITAE CORPORATION | Health Services |
| GENEDX HOLDINGS CORP. | Health Services |
| Private companies | 7 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
GeneDx, Inc.
GeneDx, Inc. Medical/Nursing ServicesHealth Services GeneDx, Inc. provides genetic testing for rare hereditary disorders. It offers diagnostic tests for gene, disease, mitochondria, inherited metabolic, and eye disorders; gene deletion/duplication analysis services; and molecular cytogenetic, prenatal genetic, mutation-specific, autism/autism spectrum disorder, cardiology genetic, and mutation confirmation tests. The company was founded by John Compton and Sherri Bale in 2000 and is headquartered in Gaithersburg, MD. | Health Services |
Rivkin Center for Ovarian Cancer
Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Rivkin Center for Ovarian Cancer is a non-profit organization that funds ovarian cancer research, screening, and educational programs for women. The company was founded by Saul E. Rivkin in 1996 and is headquartered in Seattle, WA. | Commercial Services |
| Cancan Health | |
Vivo Communications, LLC
Vivo Communications, LLC Specialty TelecommunicationsCommunications Vivo Communications, LLC provides telecommunication services. The private company is based in Seattle, WA. | Communications |
Mount Sinai Genomics, Inc.
Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Health Services |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Part of GeneDx Holdings Corp., GeneDx LLC is a private company that provides genomic testing services. The company is based in Stamford, CT. The company was founded in 2000. Katherine A. Stueland has been the CEO of the company since 2021. | Health Services |
- Stock Market
- Insiders
- Katherine Stueland
